Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Megan Hardin

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
The Journal of Allergy and Clinical Immunology. in Practice|December 13, 2023
Dupilumab Improves Lung Function Parameters in Pediatric Type 2 Asthma: VOYAGE StudyLeonard B Bacharier, Theresa W Guilbert, Constance H Katelaris, et al.
The Journal of Allergy and Clinical Immunology. Global|October 2, 2023
Preclinical and clinical experience with dupilumab on the correlates of live attenuated vaccinesMichael E Wechsler, Adelmir Souza-Machado, Christine Xu, et al.
Chest|February 26, 2022
Dupilumab Reduces Oral Corticosteroid Use in Patients With Corticosteroid-Dependent Severe Asthma: An Analysis of the Phase 3, Open-Label Extension TRAVERSE TrialLawrence D Sher, Michael E Wechsler, Klaus F Rabe, et al.
The Lancet. Respiratory Medicine|September 14, 2014
Radiological correlates and clinical implications of the paradoxical lung function response to β₂ agonists: an observational studySurya P Bhatt, James M Wells, Victor Kim, et al.
Journal of Cachexia, Sarcopenia and Muscle|January 4, 2017
Body mass index change in gastrointestinal cancer and chronic obstructive pulmonary disease is associated with Dedicator of Cytokinesis 1Merry-Lynn Noelle McDonald, Sungho Won, Manuel Mattheisen, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 4, 2022
Efficacy of dupilumab in patients with moderate-to-severe asthma and persistent airflow obstructionNicola A Hanania, Mario Castro, Eric Bateman, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 23, 2023
Dupilumab pharmacokinetics and effect on type 2 biomarkers in children with moderate-to-severe asthmaDaniel J Jackson, Leonard B Bacharier, Wanda Phipatanakul, et al.
The Lancet. Respiratory Medicine|November 13, 2023
Assessment of long-term safety and efficacy of dupilumab in children with asthma (LIBERTY ASTHMA EXCURSION): an open-label extension studyLeonard B Bacharier, Jorge F Maspero, Constance H Katelaris, et al.
Human Molecular Genetics|December 6, 2011
Identification of a chronic obstructive pulmonary disease genetic determinant that regulates HHIPXiaobo Zhou, Rebecca M Baron, Megan Hardin, et al.
Journal of the American Academy of Dermatology|June 24, 2020
Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: A randomized, double-blinded, placebo-controlled phase 3 trialAmy S Paller, Elaine C Siegfried, Diamant Thaçi, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
The Journal of Allergy and Clinical Immunology. in Practice|December 13, 2023
Dupilumab Improves Lung Function Parameters in Pediatric Type 2 Asthma: VOYAGE StudyLeonard B Bacharier, Theresa W Guilbert, Constance H Katelaris, et al.
The Journal of Allergy and Clinical Immunology. Global|October 2, 2023
Preclinical and clinical experience with dupilumab on the correlates of live attenuated vaccinesMichael E Wechsler, Adelmir Souza-Machado, Christine Xu, et al.
Chest|February 26, 2022
Dupilumab Reduces Oral Corticosteroid Use in Patients With Corticosteroid-Dependent Severe Asthma: An Analysis of the Phase 3, Open-Label Extension TRAVERSE TrialLawrence D Sher, Michael E Wechsler, Klaus F Rabe, et al.
The Lancet. Respiratory Medicine|September 14, 2014
Radiological correlates and clinical implications of the paradoxical lung function response to β₂ agonists: an observational studySurya P Bhatt, James M Wells, Victor Kim, et al.
Journal of Cachexia, Sarcopenia and Muscle|January 4, 2017
Body mass index change in gastrointestinal cancer and chronic obstructive pulmonary disease is associated with Dedicator of Cytokinesis 1Merry-Lynn Noelle McDonald, Sungho Won, Manuel Mattheisen, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 4, 2022
Efficacy of dupilumab in patients with moderate-to-severe asthma and persistent airflow obstructionNicola A Hanania, Mario Castro, Eric Bateman, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 23, 2023
Dupilumab pharmacokinetics and effect on type 2 biomarkers in children with moderate-to-severe asthmaDaniel J Jackson, Leonard B Bacharier, Wanda Phipatanakul, et al.
The Lancet. Respiratory Medicine|November 13, 2023
Assessment of long-term safety and efficacy of dupilumab in children with asthma (LIBERTY ASTHMA EXCURSION): an open-label extension studyLeonard B Bacharier, Jorge F Maspero, Constance H Katelaris, et al.
Human Molecular Genetics|December 6, 2011
Identification of a chronic obstructive pulmonary disease genetic determinant that regulates HHIPXiaobo Zhou, Rebecca M Baron, Megan Hardin, et al.
Journal of the American Academy of Dermatology|June 24, 2020
Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: A randomized, double-blinded, placebo-controlled phase 3 trialAmy S Paller, Elaine C Siegfried, Diamant Thaçi, et al.
Pageof 5